Finally, BRAF mutated cells also have angiogenic capacity (66), since they can induce other cancer cells and microenvironmental cells to secrete CXCL8 and CCL2, two pro-tumorigenic chemokines, leading to cancer cell proliferation and macrophage-mediated angiogenesis (62). This evidence concerns the gene CCL2 and cancer.